Search - tctmd.com

Displaying 761 - 780 of 9980

Sort: Relevancy | Date

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

February 19, 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

February 18, 2025

Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

News Conference News

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Yael L. Maxwell

February 18, 2025

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

AHA Scientific Statement Takes Aim at PAD Pain

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

February 13, 2025

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

February 13, 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

February 12, 2025

Acoramidis Approved in Europe for ATTR Cardiomyopathy

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Diverging Timelines: Combining Treatment Strategies to Prolong Life in Young Heart Failure Patients

Presentation THT 2025

Diverging Timelines: Combining Treatment Strategies to Prolong Life in Young Heart Failure Patients

Presenter: Manreet Kanwar

February 12, 2025

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Presentation THT 2025

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Presenter: Klas Rikner

February 12, 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presentation THT 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 12, 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presentation THT 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presenter: Eric Secemsky

February 12, 2025

Clinical Trial Updates: What's New? What's Coming?

Presentation THT 2025

Clinical Trial Updates: What's New? What's Coming?

Presenter: Jay Giri

February 12, 2025

Medical Management (Heparin/ Lytics)

Presentation THT 2025

Medical Management (Heparin/ Lytics)

Presenter: Gregory Piazza

February 12, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.